Subscribe
Magazine
Past Issues
Surveys
Industry Statistics
About Us
Members Only
Best Places to Work
General Interest
Exploration & Development
Drilling & Production
Refining & Processing
Pipelines & Transportation
LNG
Energy Transition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about DSKYF
Recent news which mentions DSKYF
Recession-Resilient Asian Stock Picks: TSMC, SK Hynix Among This Analyst's Top 10
August 07, 2024
Tickers
ALCPF
ASIA
DSKYF
DSNKY
Tags
DSNKY
Asia
HTHIF
From
Benzinga
Merck's Q2 Earnings: Revenue And EPS Beat Helped By Strong Keytruda Sales, But Acquisition Costs Bites Into Annual Profit Forecast
July 30, 2024
Tickers
DSKYF
DSNKY
MRK
NEWS
Tags
Biotech
Movers
Stories That Matter
From
Benzinga
FDA Declines To Approve Merck-Daiichi Sankyo Partnered Lung Cancer Drug
June 27, 2024
Tickers
DSKYF
DSNKY
MRK
NEWS
Tags
MRK
Market News
DSKYF
From
Benzinga
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
June 24, 2024
Tickers
ARWR
DSKYF
MRK
NEWS
Tags
Equities
DSKYF
News
From
Benzinga
Why Is AstraZeneca Stock Trading Lower On Tuesday?
May 28, 2024
Tickers
AZN
DSKYF
DSNKY
NEWS
Tags
Market News
AZN
why it's moving
From
Benzinga
Double Good News For AstraZeneca's Breast Cancer Drugs
April 29, 2024
Tickers
AZN
DSKYF
DSNKY
NEWS
Tags
breast cancer
Market News
AZN
From
Benzinga
AstraZeneca/Daiichi's Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor
April 08, 2024
Tickers
AZN
DSKYF
DSNKY
NEWS
Tags
Biotech
Benzinga
Stories That Matter
From
Benzinga
What's Going On With Pfizer Stock Today?
January 25, 2024
Tickers
DSKYF
DSNKY
NEWS
PFE
Tags
Market News
Health Care
DSKYF
From
Benzinga
Merck Signs Multi-Billion Deal With Japan's Daiichi Sankyo For Cancer Therapy Drug Development
October 20, 2023
Tickers
AZN
DSKYF
MRK
Tags
Market News
Markets
MRK
From
Benzinga
Better Than Chemotherapy - AstraZeneca/Daiichi Sankyo Partnered Cancer Drug Meets Primary Goal In Breast Cancer Setting
September 22, 2023
Tickers
AZN
DSKYF
DSNKY
Tags
AZN
General
DSNKY
From
Benzinga
AstraZeneca's Reinforces Hold In Lung Cancer Settings: Touts Promising Data From Three Trials
September 11, 2023
Tickers
AZN
DSKYF
DSNKY
Tags
General
DSNKY
Briefs
From
Benzinga
FDA Greenlights Daiichi Sankyo's Blood Cancer Drug, A Promising Competitor to Novartis' Rydapt
July 21, 2023
Tickers
DSKYF
DSNKY
NVS
Tags
Health Care
Benzinga
Biotech
From
Benzinga
AstraZeneca Shares Under Pressure On Some Adverse Events In Late-Stage Lung Cancer Drug Trial
July 03, 2023
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Market News
Markets
AZN
From
Benzinga
Daiichi, Zymeworks Terminate Seven Year-Cancer Antibody Pact
March 20, 2023
Tickers
DSKYF
DSNKY
ZYME
Tags
News
DSKYF
Health Care
From
Benzinga
AstraZeneca-Daiichi Sankyo's Flagship Cancer Drug Shows Meaningful, Durable Responses In Other Solid Tumor Setting
March 06, 2023
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
AZN
Market News
DSKYF
From
Benzinga
Daiichi Sankyo Seeks Approval In Japan For Its mRNA-Based COVID-19 Vaccine
January 13, 2023
Tickers
DSKYF
DSNKY
Tags
News
Briefs
DSKYF
From
Benzinga
AstraZeneca - Daiichi Sankyo's Enhertu Wins European Approval For Gastric Cancer, CHMP Backs Other Cancer Drugs
December 19, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
News
DSKYF
Large Cap
From
Benzinga
European Medicines Agency's Advisory Committee Backs Approval Of AstraZeneca's Three Cancer Drugs
November 14, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Health Care
DSKYF
Large Cap
From
Benzinga
With Upcoming Contentious Meeting, This Analyst Cuts Price Target On Spectrum Pharma
September 21, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Market News
Analyst Color
Analyst Ratings
From
Benzinga
Seagen Suffers Loss In Arbitration Dispute Over ADC Technology
August 15, 2022
Tickers
DSKYF
DSNKY
MRK
SGEN
Tags
Biotech
Benzinga
Health Care
From
Benzinga
AstraZeneca-Daiichi's Flagship Breast Cancer Drug Improves Survival In Late-Stage Study
August 15, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Market News
AZN
Health Care
From
Benzinga
Daiichi-AstraZeneca's Flagship Cancer Drug Scores FDA Approval For Lung Cancer Harboring HER2 Mutation
August 12, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
AZNCF
GH
DSNKY
From
Benzinga
AstraZeneca's Dato-DXd-Based Combo Therapies Show Promising Activity In Lung Cancer Patients
August 09, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
AZN
Market News
News
From
Benzinga
The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings
July 19, 2022
Tickers
ACAD
APLS
AVDL
AZN
Tags
DSNKY
Small Cap
General
From
Benzinga
AstraZeneca's Enhertu Wins European Approval For Pretreated Breast Cancer Setting
July 19, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
General
DSNKY
AZNCF
From
Benzinga
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
June 27, 2022
Tickers
ALPMF
ALPMY
AXSM
AZN
Tags
News
DSKYF
Penny Stocks
From
Benzinga
EMA's Advisory Committee Backs Approval For AstraZeneca's Targeted Breast Cancer Therapies
June 27, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
AZNCF
General
DSNKY
From
Benzinga
Morning Brief: Top Financial Stories Dominating on Monday, June 6
June 06, 2022
Tickers
AAPL
AMD
AXON
AZN
Tags
GSK
GOOG
TSLA
From
Benzinga
AstraZeneca-Daiichi Breast Cancer Drug Cuts Disease Progression Or Death Risk By Almost 50%
June 06, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Health Care
Top Stories
News
From
Benzinga
FDA Approval For AstraZeneca - Daiichi's Enhertu Expands To Earlier Use In Metastatic Breast Cancer
May 05, 2022
Tickers
AZN
AZNCF
DSKYF
Tags
General
FDA
AZNCF
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.